Skip to main content
IONIS PHARMACEUTICALS INC logo

IONIS PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · IONS ISIN · US4622221004 LEI · 549300SI4ZGLG0BLUZ92 US Manufacturing
Filings indexed 1,796 across all filing types
Latest filing 2024-11-08 Major Shareholding Noti…
Country US United States of America
Listing US IONS

About IONIS PHARMACEUTICALS INC

https://www.ionis.com/

Ionis Pharmaceuticals, Inc. is a biopharmaceutical company that discovers and develops RNA- and DNA-targeted therapeutics. Leveraging its expertise in antisense technology and a deep understanding of genetics, the company creates novel medicines designed to treat a wide range of serious diseases. Its development pipeline and marketed products primarily address neurologic and cardiometabolic disorders, as well as other areas with high unmet patient needs, including rare diseases. The company's approach aims to provide new solutions for complex and often intractable conditions by targeting the root cause of disease at the genetic level.

Recent filings

Filing Released Lang Actions
SEC SCHEDULE 13G
Major Shareholding Notification
2024-11-08 English
IONIS PHARMACEUTICALS, INC. 10-Q 9-30-2024
Interim / Quarterly Report Q3 2024
2024-11-06 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 6, 2024, reporting the company's financial results for the quarter ended September 30, 2024. It specifically states that a press release announcing quarterly financial results is furnished as an exhibit. The text does not contain the actual financial statements or detailed financial analysis but rather announces the results and provides a press release. The document length is 4054 characters, which is relatively short and consistent with an earnings release announcement rather than a full quarterly report. According to the rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER).
2024-11-06 English
PRIMARY DOCUMENT
Director's Dealing
2024-10-17 English
PRIMARY DOCUMENT
Director's Dealing
2024-10-17 English
PRIMARY DOCUMENT
Director's Dealing
2024-10-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.